Heart Fatty Acid Binding Protein (h-FABP) significantly improves diagnosis in early phase of the whole spectrum of Acute Coronary Syndromes.
Figiel L, Kasprzak JD, Wraga M, Musialowska M, Peruga JZ, Klosinska M, Krzeminska- Pakula M
Poster Presentation, ESC 2009

Clinical assessment of heart-type fatty acid binding protein in early diagnosis of acute coronary syndrome.
Valle HA, Castrillo Riesgo LG, Bel MS, Francisco Epelde Gonzalo, Sanchez MS, Oliva LI
European Journal of Emergency Medicine 2008, 15:140–144

Heart-type fatty acid binding protein--a reliable marker of myocardial necrosis in a heterogeneous group of patients with acute coronary syndrome without persistent ST elevation.
Figiel L, Kasprzak JD, Peruga J, Lipiec P, Drozdz J, Krzeminska- Pakula M , Smigielski J
Kardiol Pol. 2008 Mar;66(3):253-9.

Heart-Type Fatty Acid-Binding Protein Predicts Long-Term Mortality After Acute Coronary Syndrome and Identifies High-Risk Patients Across the Range of Troponin Values
Kilcullen N, Viswanathan K, Das R, et al.
J Am Coll Cardiol.2007;50:2061-2067.

Heart fatty acid binding protein in the diagnosis of myocardial infarction: where do we stand today?
Colli A, Josa M, Pomar JL, Mestres CA, Gherli T.
Cardiology.2007;108(1):4-10.

Prognostic utility of heart-type fatty acid binding protein in patients with acute coronary syndromes.
O'Donoghue M, de Lemos JA, Morrow DA, Murphy SA, Buros JL, Cannon CP,Sabatine MS
Circulation. 2006 Aug 8;114(6):550-7.

Unbound free fatty acids and heart-type fatty acid-binding protein: diagnostic assays and clinical applications.
Azzazy HM, Pelsers MM, Christenson RH,
Clin Chem.2006 Jan;52(1):19-29.

Diagnostic and prognostic value of heart-type fatty acidbinding protein (H-FABP), an early biochemical marker of myocardial injury.
Bertinchant JP, Polge A,
Arch Mal Coeur Vaiss. 2005 Dec;98(12):1225-31

Prognostic value of elevated circulating heart-type fatty acid binding protein in patients with congestive heart failure.
Arimoto T, Takeishi Y, Shiga R, Fukui A, Tachibana H, Nozaki N, Hirono O, Nitobe J, Miyamoto T, Hoit BD, Kubota I
J Card Fail. 2005 Feb;11(1):56-60

Alhadi HA, Fox KAA,
Do we need additional markers of myocyte necrosis :  the potential value of heart fatty-acid-binding protein.
Q J Med 2004; 97 : 187 - 198

Schulz O, Paul-Walter C, Remmler D, Lehmann M, Berghofer G, Becnsch R, Schimke I,
Verbesserung der ergometrischen Ischamiediagnostik durch Messung von Biomarkern?
Heart-type fatty acid –binding protein und kardiales Troponin I bei Patienten mit stabiler Angina pectoris.
70. Jahrestagung der  Deutschen  Gesellschaft  fur  Kardiologie,  April 2004

Haltern G,
The New Marker for Acute Myocardial Infarction: Human Heart-Type Fatty Acid Binding Protein (H-FABP).
6th Update on cardiology 2004, Mashad, Iran

Tambara K, Fujita M, Miyamoto S, Doi K, Nishimura K, Komeda M
Pericardial fluid level of heart-type cytoplasmic fatty-binding protein(H-FABP) is an indicator of severe myocardial ischemia.
Int J Cardiology 93(2004) 281-284

Kemp M, Donovan J, Higham H, Hooper J,
Biochemical markers of myocardial injury.
Br J Anaesth 2004; 93: 63±73

Chan CPY, Cheng WS, Glatz JFC, van der Voort D, Sanderson JE, Hempel A, Lehmann M, Renneberg I, Renneberg R,       
Early Diagnosis of acute myocardial infarction using immunosensors and immunotests.
Analytical Letters, Vol.36, No.9, pp. 1987-2004, 2003

Yuan Y, Kwong AWK, Kaptein WA, fong C, Tse M, Glatz JFC, Chan C, Renneberg R,
The Response of Fatty acid-Binding Protein and Creatine Kinase to Acute and Chronic Exercise in Junior Rowers.
Research quarterly for Exercise and Sport 2003; 74()3277-283

Haltern G, Fueth , Lankisch M, Lapp H, Klienn M, Scherbaum WA, Martin S, Gulker H
Stellenwert des Fettaurebindenden Proteins des Herzens (h- FABP) fur die Risikostratifizierung des Akuten Myokardinfarkts.
69. Fruhjahrstagung der Deutschen Gesellschaft fur Kardiologie 2003.

Isa R, Maluenda G Perez O, Castro P,
Comparison between the Heart Specific Fatty Acid Binding Protein and Troponin I at Chest Pain.
Poster, Congreso de Cardiologia 2003, Chile

Goto T, Takase H, Toriyama T, Sugiura T, Sato K, Ueda R, Dohi Y,
Circulating concentrations of cardiac proteins indicate the severity of congestive heart failure.
Heart 2003; 89: 1303-1307

Glatz JFC, van der Voort D, Hermens W T,
Fatty acid-binding protein as the earliest available plasma marker of acute myocardial injury.
J Clin Ligand Assay (2002)

Kaptein W, Chan C, Sanderson J, Glatz JFC, Leung W, Renneberg R,
Early detection of acute myocardial infarction with the new marker Fatty Acid-Binding Protein: rapid testing and diagnostic value.
http://barlo.ipc.uni-tuebingen.de/biosensor2001

Petzoldt T, Feindt P, Sunderdiek U, Boeken U Fischer Y, Gams E,
Heart-type fatty acid binding protein (h-FABP) in the diagnosis of myocardial damage in coronary artery bypass grafting.
Eur J Cardiothorac surg 2001; 19:859-864

De Groot MJM, Muijtjens AMM, Simoons, ML Hermens WTh, Glatz JFC,
Assesment of Coronary reperfusion in patients with myocardial infarction using fatty acid binding protein concentrations in plasma.
Heart 2001; 85: 278-285.

Aartsen WM, Pelsers MMAL, Hermens WTh, Glatz JFC, Daemen MJAP, Smits JFM,
Heart fatty acid binding protein and cardiac troponin T plasma concentrations as markers for myocardial infarction after coronary artery ligation in mice.
Eur J Physiol (2000) 439; 416-422.

Haastrup B, Gill S, Kristensen SR, Jorgensen PJ, Glatz JFC, Haghfelt T, Horder M,
Biochemical Markers of Ishaemia for the early identification of Acute Myocardial Infarction without ST Segment Elevation.
Cardiology 2000; 94: 254-261 http://www.karger.com/journals/crd

De Lemos JA, Antmann EM, Morrow DA, Llevadot j, Giuliano RP, Coulter SA,Schuhwerk, KC, Arslanian S, McCabe CH, Gibsn CM, Rifai N,
Heart-Type Fatty Acid Binding Protein as a marker of reperfusion after thrombolytic therapy.Clin Chim Acta 298 (2000) 85-97  http://www.elsevier.com/locate/clinchim

Hoekstra J. Glycoprotein,
llb/llla receptor inhibitor use in unstable angina/non-ST-segment elevation myocardial infarction:
an appropriate-use model for the emergency department.
J Emergency Med, Vol.19 (2000) 13-19

Okamoto F, Saohmiya K, Ohkaru Y, Kawamura K, Asayama K, Kimura H, Nishimura S, Inshii H,Sunhara N, Tanaka T.
Human heart-type cytoplasmic Fatty acid-binding protein (H-FABP) for the diagnosis of acute myocardial infarction. Clinic evaluation of H-FABP in comparison with myoglobin and creatine kinase isoenzymen MB.
Clin Chem Lab Med 2000 Mar; 38 (3): 231-8
http://www.degruyter.de/journals/cclm

Pentilla I, Pentilla K, Rantanen T,
Laboratory diagnosis of patients with acute chest pain.
Clin Chem Lab Med 2000 Mar; 38 (3):187-197

Pelsers MMAL, Chapelle JP, Knapen M, Vermeer C, Muijtjens AMM, Hermens WTh, Glatz JFC,
Influence of Age and Sex and Day-to-Day and within-day Biological Variation on plasma Concentrations of fatty Acid-binding protein and Myoglobin in HealthySubjects.
Clinical Chemistry 45, No. 3, 1999

De Groot MJM, Wodziog KWH, Simoons ML, Glatz JFC, Hermens WTh,
Measurement of myocardial infarct size from plasma fatty acid-binding protein or myoglobin, using individually estimated clearance rates.
Cardiovascular Research 44 (1999) 315-324
http://www.elsevier.com/locate/cardiores

Glatz JFC, van der Vusse GJ, Simoons ML, Kragten JA, van Dieijen-Visser MP, Hermens WTh,
Fatty acid-binding protein and the early detection of acute myocardial infarction.
Clin Chim Acta 272 (1998) 87-92
http://www.elsevier.com/locate/clinchim

Glatz JFC,
Fatty Acid-Binding Protein as a Plasma Marker for the Early Detection of Myocardial Injury. Myocardial Damage:
Early Detection by Novel Biochemical Markers.
Kluwer Academic Publishers, Dev Cardiocasc Med 205, pp. 73-84, 1998

Schrieber A, specht B, Pelsers MM, Glatz JF, Borchers T, Spener
Recombinant human heart-type fatty acid-binding protein as standard in immunochemical assays.
Clin Chem Lab Med 1998; 36: (5) 283-288

Wedzig KWH, Kragten JA, Modrzejewski W, Gorski J, van Dieejen-Visser MP, Glatz JFC, Hermens WTh,
Thrombolytic therapy does not change the release rations of enzymatic and non-enzymatic myocardial marker proteins.
Clin Chem Acta 272 (1998) 209-223
http://www.elsevier.com/locate/clinchim

Sanders GT, Schouten Y, De winter RJ, et al.
Evaluation of human heart type fatty acid-binding protein assay for early detection of myocardial infarction.
Clin Chim 1998; 44: A132 (abstract):
http://www.clinchim.org, http://www.degruyter.de/journals/cclm

Glatz JFC, Haastrup B, Hermes WT, et al,
Fatty acid-binding protein and the early detection of acute myocardial infarction:the EUROCARDI multicenter trial.
Circulation 1997;96: I-215 (abstract)
http://circ .ahajournals.org

Glatz JFC, EUROCARDI study team
Fatty acid-binding protein and the early detection of acute myocardial infarction:
Ned Tijdschr Klin Chem 1997;22:91-111

Gorski J, Hermes WT, Borawski J, Mysliwiec M, Glatz JFC,
Increased Fatty Acid Binding Protein Concentration in Plasma of Patients with Chronic Renal Failure.
Clin Chem 1997; 43:193A-195.
http://www.clinchem.org ,  http://www.degruyter.de/journals/cclm

Ishii J, Nagamura Y, Nomura M, Wang J, Taga S, Kinoshita M, Kurokawa H, Iwase M, Kondo T, Watanabe Y, Hishida H, Tanaka T, Kawamura K,
Early detection of successful coronary reperfusion basedon serum concentration of human heart-type cytoplasmic fatty acid-binding protein.
Clin Chim Acta 262 (1997) 13-27
http://www.elsevier.com/locate/clinchim

Ishii J, Wang J, Naruse h, Taga S, Kinoshita M, Kurokawa H, Iwase M, Kondo T, Nomura M, Nagamura Y, Watanabe Y, Hishida H, Tanaka T, Kawamura K,
Serum concentrations of myoglobin vs human heart-type cytoplasmic fatty acid-binding protein in early detection of acute myocardial infarction.
Clin Chem 43, No.8 (1997) 1372-1378

Glatz JFC, Van der Vusse GJ,
Cellular fatty acid-binding proteins. Their function and physiological significance.
Prog Lipid Res 1996; 35:243-282.

Siegmann-Thoss C, Renneberg R, Glatz JFC, et al,
Enzyme immunosensor for diagnosis of myocardial infarction.
Sensors Actuators 1996, B 30: 71-76

Yoshimoto K, Tanaka T, Somiya K et al,
Human heart-type cytoplasmic fatty acid-binding protein as an indicator of acute myocardial infarction.
Heart Vessels 1995; 10: 304-309

Van Nieuwenhoven FA, Klieine AH, Wodzig KWH, Hermens WT, Kragten HA, Maessen JG, Punt CD, Van Dieijen MP, Van Der Vusse GJ, Glatz JFC,
Discrimination Between Myocardial and Skeletal Muscle injury by Assessment of the Plasma Ratio of Myoglobin Over Fatty Acid-Binding Protein. Circulation.
1995; 92:2848-2854

GlatzJFC, Kleine AH, van Nieuwenhoven FA, Hermens WT, Van Dieijen-Visser MP, van der Vusse GJ,
Fatty acid-binding protein as a plasma marker for the estimation of myocardial infarct size in humans.
British Heart Journal, Vol 71 (1994) 135-140

Sohmiya K, Tanaka T, Tsuji R, Yoshimoto K, Nakayama Y, Hirota Y, Kawamura K, Matsaunaga Y, Nishimura S, Miyazaki H,
Plasma and Urinary heart-type Cytoplasmic Fatty Acid-Binding Protein in Coronary Occlusion and Reperfusion Included Myocardial Injury Model.
Journal of Molecular and Cellular Cardiology 25 (1993); 12: 1413-1426

Tsuji R, Tanaka T, Sohmiya K, Hirota Y, Yoshimoto K, Kinoshita K, Kusaka Y, Kawamura K, Morita H, Abe S, Tanaka H,
Human heart-type cytoplasmic fatty acid-binding protein in serum and urine during hyperacute myocardial infarction.
Int J Card 41 (1993) 209-217

Kliene AH, Glatz JFC, Van Nieuwenhoven FA, Van der Vusse GJ,
Release of heart fatty acid-binding protein into plasma after acute myocardial infarction in man.
Molecular and Celllular Biochemistry 116:155-162, 1992

Glatz JFC, Van Bilsen m, Paulussen RJA, et al,
Release of heart fatty acid-binding protein from isolated rat heart subjected to ischemia and reperfusion or to the calcium paradox.
Biochim Biophys Acta 1988; 961:148-152.